Nike will be releasing earnings next week. Management already prepared us to not expect any major wins.
For context, if you had invested $10,000 into Nike in late 2022, your investment would today be worth around $2,351.
A lot seems to have gone wrong with the company in recent years, and the worst part is that this seems to mostly have been self-inflicted.
Went all in direct to consumer, cut wholesale partners, destroyed those relationships
Flooded the market with AF1, AJ1, Dunks, and killed the heat on some of their best franchises
They chased lifestyle revenue, and pretty much abandoned the sport performance identity (major strategic blunder imo).
One of their worst moves was to build a fixed-cost infrastructure for a digital business that never ended up reaching the scale management projected.
Misread China’s channel dynamics and let inventory pile up across digital and wholesale simultaneously
Its EMEA markets showed structural mismanagement, so the management’s response was to paper over it with volume, rather than addressing structural causes of weakness.
Tried to fix all of it at once from a position of weakened brand equity and elevated inventory everywhere which just worsened things for itself.
Management now insists that they are working to correct these misteps. The main thesis they’re trying to push is that the company never lost its fundamental advantages (athlete relationships, innovation capability, brand equity, wholesale infrastructure, global scale, etc.) and all wrongs actually related to discipline.
In prior earning calls, they seem to be pretty explicit that the timeline is longer than they initially suggested and some geographies are messier than initially diagnosed. China and EMEA have structural weaknesses compared to North America, and require more time.
They have guided Q4 revenue to fall between 2% and 4% of last year Q4’s total of $11.1 billion. If the reported revenue is below $10.6 billion, that’s going to be really negative for the Nike. They’re betting on the North American market showing strength, and if that does not play out, their thesis is breaking down.
Personally, I think the stock is expensive right now at 28x forward earnings, especially since the best signal we could be given is that the fundamental decline is slowing, not reversing. I think that’s a pretty thin foundation for a 28x multiple.
What to watch now
As promised, here is the Cheat Sheet that contains the 25 Milestones I am watching closely, which would help us understand whether or not the management’s thesis is actually playing out. Keep in mind, even management does not expect extraordinary recovery to show up right now. The bar here is not recovery. It is whether the damage is being contained, and whether the right signals are starting to show up underneath the headline numbers:
Based on these milestones, I’ve developed a tranch system that will help us decide whether the stock should get a positive, negative, or neutral rating in the upcoming earnings:
TRANCHE DECISION FRAMEWORK
ADD
Any 5 of the following 7 conditions met, with no Critical misses: (1) Running sustains double-digit growth in Q4 FY2026; (2) Q4 revenue lands within guided -2% to -4% range with North America positive; (3) Spring 2027 Sport Offense product ramp executes on schedule; (4) North America Digital discounts continue declining sequentially; (5) Gross margin expansion confirmed in Q2 FY2027; (6) Football, training, and basketball return to growth within 2 quarters; (7) Investor Day held fall CY2026 with quantitative long-term targets.
HOLD
Win Now action timeline intact (CY2026 completion), Running growth sustained, North America sequential improvement continuing — but one or two High milestones slipping (e.g., football/training ramp delayed one quarter, EMEA inventory cleanup extending into Q1 FY2027, Digital discounts flattish rather than improving). No Critical commitments explicitly walked back.
CUT
Any 2 of the following: (1) CY2026 Win Now completion deadline pushed explicitly; (2) Spring 2027 Sport Offense product launch underwhelms on sell-through; (3) North America growth reverses — all-channel positive February signal does not hold in Q4; (4) Q2 FY2027 gross margin expansion fails to materialize; (5) Running growth decelerates below double digits for two consecutive quarters. OR: single occurrence of Hill or Friend explicitly walking back the CY2026 Win Now completion language.
ROADMAP ADD CALLS
Spring 2027 Sport Offense product ramp: first clean look at the new product architecture hitting shelves. If sell-through is strong, this is the ADD moment before the broader revenue recovery is fully priced in.
Q2 FY2027 earnings: the gross margin inflection quarter. If expansion materializes as guided, the transitory-costs narrative is confirmed and the earnings recovery arc becomes investable.
Investor Day (fall CY2026): if long-term quantitative targets are disclosed and the 2027–2028 innovation pipeline is compelling, this is a potential re-rating catalyst.
World Cup 2026 (June–July): if Mercurial launch, federation kit execution, and 5,000-door retail presence land well, the football category momentum becomes a visible second pillar alongside running.
Upcoming earnings are very critical because NIKE has stacked its entire credibility on a sequence of very specific, time-bound commitments. I feel that the next two to three quarters are when the market finds out if those commitments hold.
Management gave us a map. Upcoming earnings are where we will find out if the map matches the terrain.
Immediately after the earnings drop, I’ll be publishing a full post-earnings diagnostic, milestone by milestone, and what it means for the position.
Make sure you’re subscribed so you don’t miss out!
Want this level of analysis done exclusively for a stock on your portfolio? Commission a custom Earnings Scorecard here.